Book value per share increased to $156.63, representing a compounded annual growth rate of 9.7% since 2021.
Consolidated net premiums increased 14% year-over-year, with traditional business premiums up 11% on a constant currency basis, driven by strong growth in the U.S., EMEA, and Asia.
Excess capital increased to $3.8 billion at the end of Q2, or $2.3 billion pro forma for the Equitable transaction; deployable capital rose to $3.4 billion.
Investment income was strong, with a nonspread portfolio yield of 4.98% (up 8 basis points from Q1) and total variable investment income of $105 million, driven by realizations in limited partnerships and real estate joint ventures.
RGA reported operating EPS of $4.72 per share for Q2 2025, with an adjusted operating return on equity (ROE) of 14.3% for the trailing 12 months, in line with intermediate-term targets.
The effective tax rate was 25.2% for the quarter, above the expected 23%-24%, due to valuation allowances on foreign tax credits, but full-year tax rate guidance remains unchanged.
The quarter's results were below expectations due to large claims volatility in U.S. individual life and unfavorable claims in the healthcare excess business within U.S. Group.
Hippo achieved positive net income from operating activities for the first time, with Q2 net income of $1 million and adjusted net income of $17 million, reflecting a $41 million and $37 million improvement respectively compared to Q2 2024.
Hippo reported gross written premium growth of 16% year-over-year to $299 million in Q2 2025, driven by organic growth and new hybrid fronting programs.
Operating expenses decreased by 16% year-over-year, falling from 46% to 30% of revenue, demonstrating improved operating leverage.
Revenue increased 31% year-over-year to $117 million, supported by a 12% growth in gross earned premium and a 9 percentage point increase in premium retention to 39%.
The consolidated net loss ratio improved significantly by 46 percentage points year-over-year to 47%, aided by underwriting actions, claims improvements, and favorable reserve developments.